Stay updated with breaking news from Secured Note. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023.Balance Sheet InformationCash, cash equivalents, and restricted cash...
AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023. Balance... | May 12, 2023
Restructuring Support Agreement Supported by Holders of More Than 80% of the Company's Senior Secured Notes and 100% of the Company's Second Lien Term Loans Transaction Will Significantly Strengthen... | May 1, 2023
Item 1.01 Entry into a Material Definitive Agreement. On April 26, 2023, Aridis Pharmaceuticals, Inc. entered into a Note Purchase and Loan Restructuring Agreement with Streeterville Capital, LLC .... | May 1, 2023
AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended... | March 31, 2023